Tobacco Use Cessation
3
Pipeline Programs
3
Companies
4
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
U
VARENICLINE TARTRATEApproved
varenicline tartrate
Unknown Companyoral2023
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Alliance PharmaceuticalsUK - Wiltshire
1 programHealthy Futures: Alternative-to-Suspension CurriculumN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
PfizerVarenicline Tartrate
PfizerVarenicline Tartrate
PfizerVarenicline Tartrate
Alliance PharmaceuticalsHealthy Futures: Alternative-to-Suspension Curriculum
Clinical Trials (4)
Total enrollment: 2,612 patients across 4 trials
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
Start: Aug 2008Est. completion: Jul 2009
Phase 4Completed
An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation
Start: Jul 2008Est. completion: Sep 200824 patients
Phase 1Completed
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
Start: Oct 2007Est. completion: Feb 200848 patients
Phase 1Completed
An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention
Start: Mar 2025Est. completion: Aug 20272,540 patients
N/AEnrolling By Invitation
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space